Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality

ClinicalTrials.gov ID: NCT00065156

Public ClinicalTrials.gov record NCT00065156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Single-arm, Open-label Study of the Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion-dependent Subjects With Myelodysplastic Syndromes Associated With a Del(5q) Cytogenetic Abnormality.

Study identification

NCT ID
NCT00065156
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celgene
Industry
Enrollment
148 participants

Conditions and interventions

Interventions

  • lenalidomide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2003
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Nov 18, 2019

2003 – 2008

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Arizona Cancer Center Scottsdale Arizona 85258
Mayo Clinic Scottsdale Arizona 85259
Arizona Cancer Center Tucson Arizona 85724-5024
Desert Hematology & Oncology Medical Group Rancho Mirage California 92270
Stanford University Medical Center Stanford California 94305-5750
Mayo Clinic Jacksonville Florida 32224
Cancer & Blood Disease Center Lecanto Florida 34461
University of Miami Sylvester Comp Cancer Center Miami Florida 33136
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612-9497
Northwest Georgia Oncology - Wellstar Cancer Research Marietta Georgia 30060
Rush-Presbyterian- St. Luke's Medical Center Chicago Illinois 60612
University of Chicago Medical Center Chicago Illinois 60637-1470
Midwest Cancer Research Group Skokie Illinois 60077
Johns Hopkins Oncology Center Baltimore Maryland 21287-8963
Dana-Farber Cancer Institute Boston Massachusetts 02115-6084
Wayne State University School of Medicine Detroit Michigan 48201-2097
Mayo Clinic Rochester Minnesota 55905
University of Nebraska Medical Center Omaha Nebraska 68198-7680
Roswell Park Cancer Institute Buffalo New York 14263
New York Hospital-Cornell New York New York 10021-0034
Memorial Sloan-Kettering Cancer Center New York New York 10021-6007
Mt. Sinai Medical Center New York New York 10029
University of Rochester- James P. Wilmot Cancer Center Rochester New York 14642
Wake Forest University School of Medicine Winston-Salem North Carolina 27157-1082
The Cleveland Clinic Foundation Cleveland Ohio 44195
Oregon Health & Science University Portland Oregon 97201
Kaiser Permanente Northwest Region Portland Oregon 97227
Western Pennsylvania Cancer Institute Pittsburgh Pennsylvania 15224
MD Anderson Cancer Center Houston Texas 77030
Swedish Cancer Institute Seattle Washington 98104
Fred Hutchinson Cancer Research Center Seattle Washington 98109-4417

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00065156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00065156 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →